Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose ...

Availability of GLP-1 receptor agonists with managed care organization (MCO) plans has remained under 60% since 2020. Access to tirzepatide (Mounjaro, Zepbound) was nearly completely restricted ...

CMS clawed back $13.2 million in money improperly sent to Molina Healthcare as a result of what the Justice Department ...

Medicaid spends more than half its budget on medical and long-term care for frail, low-income older adults and younger people with disabilities.

Millions of Medicaid beneficiaries have limited access to Type 2 diabetes medications that reduce the risk of cardiovascular disease, according to a study published April 22 in Annals of Internal ...